Diabetes and Pregnancy
 

Diabetes and Pregnancy

    

Diabetes in Pregnancy

Home
Pregnancy Calendar
Pregnancy
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy Date Calculator
Symptoms & Signs
Pregnancy - Antenatal Care
Pregnancy
Gestational Age
Gestational Age Intro
Morning Sickness
Smoking
Obesity
Diabetes in Pregnancy
Gestational Diabetes
Liver
Infections
Teen Pregnancy
Depression in Pregnancy
Headache
PET Definitions
Aetiology - Pre-Eclampsia and Eclampsia
Antepartum Haemorrhage
Intrautrine Growth Restriction - IUGR
Breech Presentation
Twins
Teenage Pregnancy.
Thromboprophylaxis in pregnancy and the puerperium
Premature Labour
Post-Maturity
Induction Of Labour
Planned Delivery
Water Birth
Operative Vaginal Delivery-Forceps Delivery
Vacuum Extraction Delivery
Shoulder Dystocia
Caesarean Section
Pregnancy and Childbirth
Obstetric Emergencies
Puerperium
Post-Partum Haemorrhage
Uterine Rupture
Childbirth
Perinatal Mortality
Breast Feeding
 

DIABETES IN PREGNANCY

 

 

DIABETES IN PREGNANCY - PRE-PREGNANCY PLANNING

 

 

BMJ. 2004 Apr 17;328(7445):915.

Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands.
Evers IM, de Valk HW, Visser GH.

Department of Obstetrics, University Medical Center Utrecht, PO Box 85090, 3508 AB, Utrecht, Netherlands. ingwil@worldonline.nl

Objectives:

To investigate maternal, perinatal, and neonatal outcomes of pregnancies in women with type 1 diabetes in the Netherlands.

Design:

Nationwide prospective cohort study.

Setting:

All 118 hospitals in the Netherlands. PARTICIPANTS: 323 women with type 1 diabetes who became pregnant between 1 April 1999 and 1 April 2000.

Main Outcome Measures:

Maternal, perinatal, and neonatal outcomes of pregnancy.

Results:

84% (n = 271) of the pregnancies were planned. Glycaemic control early in pregnancy was good in most women (HbA(1c) < or = 7.0% in 75% (n = 212) of the population), and folic acid supplementation was adequate in 70% (n = 226). 314 pregnancies that went beyond 24 weeks' gestation resulted in 324 infants. The rates of pre-eclampsia (40; 12.7%), preterm delivery (101; 32.2%), caesarean section (139; 44.3%), maternal mortality (2; 0.6%), congenital malformations (29; 8.8%), perinatal mortality (9; 2.8%), and macrosomia (146; 45.1%) were considerably higher than in the general population. Neonatal morbidity (one or more complications) was extremely high (260; 80.2%). The incidence of major congenital malformations was significantly lower in planned pregnancies than in unplanned pregnancies (4.2% (n = 11) v 12.2% (n = 6); relative risk 0.34, 95% confidence interval 0.13 to 0.88).

Conclusion:

Despite a high frequency of planned pregnancies, resulting in overall good glycaemic control (early) in pregnancy and a high rate of adequate use of folic acid, maternal and perinatal complications were still increased in women with type 1 diabetes. Neonatal morbidity, especially hypoglycaemia, was also extremely high. Near optimal maternal glycaemic control (HbA1c < or = 7.0%) apparently is not good enough.

Back Home Up Next

 

DIABETES

Type 1
Gestational Diabetes